Literature DB >> 7657290

Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet.

M T Bardella1, M Fraquelli, M Quatrini, N Molteni, P Bianchi, D Conte.   

Abstract

The prevalence of hypertransaminasemia and the effect of gluten-free diet (GFD) were evaluated in 158 consecutive adult celiac patients, 127 women and 31 men, aged 18 to 68 years (mean, 32). At diagnosis, 67 patients (42%) had raised aspartate and/or alanine transaminase levels (AST and ALT; mean, 47 IU/L, range, 30 to 190; and 61 IU/L, range, 25 to 470, respectively), whereas 91 patients had normal liver function tests (LFT). Patients with and without hypertransaminasemia were comparable for epidemiological data, body mass index (18.5 vs. 19.6), and severity of intestinal histological involvement. All patients were given a strict GFD and were followed for 1 to 10 years (median, 4). At 1 year, a highly significant improvement in intestinal histology was observed in both groups (P < .0001). In the 67 patients with raised transaminase levels body mass index (BMI) also increased significantly (from 18.5 to 21.0, P < .001), and transaminase levels normalized in 60 (95%). In the other seven cases liver biopsy showed fatty infiltration in two and chronic active hepatitis (CAH) in the other five, related to chronic infection with hepatitis B virus in three and hepatitis C virus in one, and to autoimmune type in the fifth. We conclude that in adult celiac patients elevated serum transaminases are a frequent finding and normalize in most cases after GFD. When they persist, liver biopsy is mandatory to further investigate hepatic involvement, which is our series was mainly attributable to CAH.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7657290

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  56 in total

Review 1.  Celiac disease in pediatric patients with autoimmune hepatitis: etiology, diagnosis, and management.

Authors:  Fabio Panetta; Valerio Nobili; Maria Rita Sartorelli; Raffaele Edo Papa; Francesca Ferretti; Arianna Alterio; Antonella Diamanti
Journal:  Paediatr Drugs       Date:  2012-02-01       Impact factor: 3.022

2.  Seroprevalence, correlates, and characteristics of undetected coeliac disease in England.

Authors:  J West; R F A Logan; P G Hill; A Lloyd; S Lewis; R Hubbard; R Reader; G K T Holmes; K-T Khaw
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

3.  Hepatobiliary Quiz (Answers)-15 (2015).

Authors:  Sahaj Rathi; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2015-10-27

4.  Systemic autoimmune disorders associated with celiac disease.

Authors:  Jason Slate; Perry Hookman; Jamie S Barkin; Richard S Phillips
Journal:  Dig Dis Sci       Date:  2005-09       Impact factor: 3.199

Review 5.  Hepatobiliary and pancreatic disorders in celiac disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

6.  The changing face of celiac disease.

Authors:  R Lad; K Jacobson
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

7.  Clinical features of chronic C virus hepatitis in patients with celiac disease.

Authors:  M Silano; U Volta; O Vincentini; M De Vincenzi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-06-16       Impact factor: 3.267

Review 8.  Coeliac disease and liver dysfunction.

Authors:  S Davison
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

9.  Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis.

Authors:  U Volta; L De Franceschi; N Molinaro; F Cassani; L Muratori; M Lenzi; F B Bianchi; A J Czaja
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

10.  Prevalence of abnormal liver function tests in celiac disease and the effect of a gluten-free diet in the US population.

Authors:  Natalia E Castillo; Rohini R Vanga; Thimmaiah G Theethira; Alberto Rubio-Tapia; Joseph A Murray; Javier Villafuerte; Alan Bonder; Rupa Mukherjee; Joshua Hansen; Melinda Dennis; Ciaran P Kelly; Daniel A Leffler
Journal:  Am J Gastroenterol       Date:  2015-07-07       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.